ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0362

Development of a Theory-based Digital Messaging Program to Reduce Fatigue in Systemic Lupus Erythematosus

Anna Deck1, Paula Caras2, Kiran Singh3, Monique Gore-Massy4, Faye Chiu5, Sara Folta6 and Shanthini Kasturi3, 1Tufts University School of Medicine, Portland, ME, 2Tufts University School of Medicine, Boston, MA, 3Tufts Medical Center, Boston, MA, 4Lupus Foundation of America, New Jersey, 5N/A, New York City, NY, 6Tufts University/Tufts University Friedman School of Nutrition, Boston, MA

Meeting: ACR Convergence 2024

Keywords: Fatigue, Patient reported outcomes, physical activity, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Patient Outcomes, Preferences, & Attitudes Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Fatigue is the single most prevalent symptom of systemic lupus erythematous (SLE), affecting 80-90% of patients, and is often refractory to pharmacologic therapy. Non-pharmacologic approaches, such as physical activity interventions, have shown promise in reducing fatigue, but have been limited by their lack of a rigorous approach to behavior change. Here we describe the development of a behavioral theory-based digital messaging intervention to increase physical activity and reduce SLE-related fatigue.

Methods: The digital messaging intervention was grounded in social cognitive and self-determination theories and was designed to promote physical activity and provide evidence-based information about SLE-related fatigue. Messages were: 1) adapted from a published behavioral theory-based physical activity messaging intervention and 2) created de novo to address themes previously identified as important to individuals with SLE. Messages were coded by content area and behavior change technique and written with attention to readability and autonomy-supportive language. Newly developed messages were then reviewed by individuals with SLE, who completed surveys rating message usefulness using a 5-point Likert scale. They provided open-ended feedback in semi-structured interviews conducted online via Zoom. Interviews were recorded and transcribed, and a thematic analysis was performed. Messages were refined based on participant feedback.

Results: A total of 148 messages were reviewed as part of the development project. 69 messages were modified from the published intervention, and 49 messages related to physical activity and 30 messages related to fatigue were created de novo. Ten individuals with SLE (Table 1) provided feedback on the 79 new messages. Overall, participants rated the messages highly (Figures 1 & 2), with an average message rating of 1.3 [out of 5, where 1 is highest]. Thematic analysis of interview feedback revealed three key themes: 1) mixed feelings around the term “lupus warrior”; 2) the importance of using autonomy-supportive messages; and 3) the importance of non-intimidating language around physical activity. Based on this feedback, 27 messages were modified, 4 were removed, and 11 new messages were created to provide additional patient-requested content.

Conclusion: We used a patient-centered approach to develop a digital messaging intervention for SLE-related fatigue that was grounded in behavior change theory. Patients rated the messages highly and provided feedback used to refine message content and language. The feasibility and efficacy of the messaging intervention will be evaluated in a future pilot study.

Supporting image 1

Table 1. Interview participant characteristics (n=10).

Supporting image 2

Figure 1. Ratings of physical activity messages by participants (n=9).

Supporting image 3

Figure 2. Ratings of fatigue messages by participants (n=9).


Disclosures: A. Deck: None; P. Caras: None; K. Singh: None; M. Gore-Massy: Aurinia Pharmaceuticals, 1, Bristol-Myers Squibb(BMS), 6, Johnson & Johnson, 1, 6; F. Chiu: None; S. Folta: None; S. Kasturi: GlaxoSmithKlein(GSK), 1.

To cite this abstract in AMA style:

Deck A, Caras P, Singh K, Gore-Massy M, Chiu F, Folta S, Kasturi S. Development of a Theory-based Digital Messaging Program to Reduce Fatigue in Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/development-of-a-theory-based-digital-messaging-program-to-reduce-fatigue-in-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-of-a-theory-based-digital-messaging-program-to-reduce-fatigue-in-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology